Opdivo Qvantig™ (nivolumab and hyaluronidase-nvhy)
for Gastric Cancer Stomach Cancer
Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) is used to treat the same solid tumor cancers as Opdivo but is not approved for use in children or with Yervoy. It is approved for adult treatment of melanoma, bladder cancer (urothelial carcinoma), colorectal cancer, gastric, gastroesophageal junction, and esophageal cancer, kidney cancer (renal cell carcinoma), liver cancer (hepatocellular carcinoma), non-small cell lung cancer (NSCLC), and squamous cell cancer of the head and neck.
